Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorDuke University

About this trial

Parents of young children in the intensive care unit may be faced with decisions about their child's care. The Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE) intervention was designed to help support parents as they make decisions for their child and communicate with the health care team. The main questions this study aims to answer are:

1. Do parents who receive the BRIDGE intervention report being better prepared to make decisions for their child? 2. Do parents who receive the BRIDGE intervention report less regret about the decisions they made for their child?

Participants will complete surveys at baseline and approximately 2 weeks, 6 months, and 12 months following enrollment. Some participants will also participate in interviews about their experiences.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age < 5 years

Admission to a critical care unit within the preceding 14 days

An anticipated serious health care decision, defined as a decision about initiating, not initiating, or withdrawing life-sustaining treatment and/or a decision about major intervention.

Age ≥ 18 years

Disqualifiers

Children, parents or clinicians who do not meet the inclusion criteria above.

Trial design

Design model

Parallel

Treatments tested in this trial

  • BRIDGE intervention

    Behavioral

    The BRIDGE intervention includes a paper-based tool that includes an introduction to decision-making, a values clarification exercise, and a question prompt list. The tool additionally prompts parents to share how they define decision-relevant concepts like quality of life and suffering for their child. The completed tool is shared with the health care team in the electronic health record.

Treatment groups

495 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Parent Preparation for Decision Making, as measured by the PrepDM

Items can be summed and scored. Score ranges from 0-100, where a higher score indicates higher perceived preparedness for decision making.

Time frame
Approximately 10-14 days following enrollment
2

Decisional Regret, as measured by the Decision Regret Scale

Decisional Regret will be measured by the Decision Regret Scale (DRS): The DRS is a 5- item scale used to measure distress or remorse after a health care decision.

Time frame
Approximately 6 and 12 months following enrollment

Secondary outcomes

1

Shared Decision Making Quality, as measured by the CollaboRATE (Parent version)

This survey is a 3-item measure, and each item can be rated from 0 to 9. Higher scores indicate a higher degree of shared decision making.

Time frame
Approximately 10-14 days following enrollment
2

Communication Quality, as measured by the Interpersonal Processes of Care (IPC-18)

For this measure, we will administer the communication and decision making subscales. Each item uses a response scale of 1-5. Higher scores indicate that the labeled interpersonal process occurred more often.

Time frame
Baseline; Approximately 10-14 days following enrollment
3

Decisional Conflict, as measured by the Decisional Conflict Scale

The Decisional Conflict Scale includes 16 items across 5 domains (score range: 0-100). Higher scores indicate a higher degree of decisional conflict.

Time frame
Approximately 10-14 days following enrollment; Approximately 6 and 12 months following enrollment
4

Parent Self-efficacy, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Self-efficacy for Managing Chronic Conditions

Participants will complete the PROMIS self-efficacy for managing chronic conditions measure, which has been adapted for use by parents. This measure assesses parental self-efficacy in managing their child's medications and treatments. Participants will complete the questions in the health care information or decision making domain. Items ask participants to indicate their current level of confidence in each behavior and have 5 response options (range 1-5). Higher scores indicate a higher level of confidence.

Time frame
Approximately 6 and 12 months following enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Duke University

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator